For years, Tokyo residents woke to the sound of crows ripping open rubbish bags, the city’s backstreets strewn with the remains of last night’s dinners. Today those scenes have mostly disappeared, thanks to a 25-year campaign to curb the crow population. A survey conducted in December showed the number of crows in Japan’s capital had fallen to less than 20 per cent of its early-2000s peak. City of...
For years, Tokyo residents woke to the sound of crows ripping open rubbish bags, the city’s backstreets strewn with the remains of last night’s dinners. Today those scenes have mostly disappeared, thanks to a 25-year campaign to curb the crow population. A survey conducted in December showed the number of crows in Japan’s capital had fallen to less than 20 per cent of its early-2000s peak. City officials and bird experts say the success stems from a mix of civic discipline, careful waste...
Last month, the United States announced its decision to sell advanced weapons amounting to US$11.1 billion to China’s Taiwan region. The authorisation of the largest ever arms package to Taiwan since China and the US established diplomatic relations has seriously violated the one-China principle and the three China-US joint communiqués, severely undermined Chinese sovereignty and security interest...
Last month, the United States announced its decision to sell advanced weapons amounting to US$11.1 billion to China’s Taiwan region. The authorisation of the largest ever arms package to Taiwan since China and the US established diplomatic relations has seriously violated the one-China principle and the three China-US joint communiqués, severely undermined Chinese sovereignty and security interests, gravely interfered in China’s internal affairs and sent the wrong signals to “Taiwan...
Exclusive: Chinese officials are using a ‘highly specific’ interpretation of EU rules to suggest Taiwanese figures should not be granted visas, officials say Chinese officials have been pushing “legal advice” on European countries, saying their own border laws require them to ban entry to Taiwanese politicians, according to more than half a dozen diplomats and officials familiar with the matter. T...
Exclusive: Chinese officials are using a ‘highly specific’ interpretation of EU rules to suggest Taiwanese figures should not be granted visas, officials say Chinese officials have been pushing “legal advice” on European countries, saying their own border laws require them to ban entry to Taiwanese politicians, according to more than half a dozen diplomats and officials familiar with the matter. The officials made demarches to European embassies in Beijing, or through local embassies directly to European governments in their capital cities, warning the European countries not to “trample on China’s red lines”, according to the European diplomats and ministries who spoke to the Guardian. Continue reading...
Merck & Co. wants to strike more deals, seeing an opportunity for “multi tens of billion”-dollar acquisitions. “We are not limited from a balance sheet — it’s more where do we see strategic opportunity,” Chief Executive Officer Rob Davis said at the JPMorgan Healthcare Conference in San Francisco. The comments come amid speculation that Merck is in talks to buy cancer drugmaker Revolution Medicine...
Merck & Co. wants to strike more deals, seeing an opportunity for “multi tens of billion”-dollar acquisitions. “We are not limited from a balance sheet — it’s more where do we see strategic opportunity,” Chief Executive Officer Rob Davis said at the JPMorgan Healthcare Conference in San Francisco. The comments come amid speculation that Merck is in talks to buy cancer drugmaker Revolution Medicines Inc. The Financial Times reported last week, citing a person familiar, that the price tag being discussed was between $28 billion and $32 billion. Merck is seeking deals to expand its portfolio of treatments as it prepares for patent losses that are expected to erode its sales by $18 billion over the next five years. In 2028, Merck faces a patent expiration for Keytruda, the best-selling drug in pharmaceutical history that accounted for more than half the company’s revenue in 2024.
(RTTNews) - The Japanese stock market is trading sharply higher on Tuesday, extending the sharp gains in the previous session, following the broadly positive cues from Wall Street overnight. The Nikkei 225 is surging 3.5 percent to above the 53,750 level, with gains across most s
(RTTNews) - The Japanese stock market is trading sharply higher on Tuesday, extending the sharp gains in the previous session, following the broadly positive cues from Wall Street overnight. The Nikkei 225 is surging 3.5 percent to above the 53,750 level, with gains across most s
(RTTNews) - Abbisko Therapeutics Co., Ltd. announced that the U.S. Food and Drug Administration (FDA) has formally accepted the New Drug Application (NDA) for pimicotinib (ABSK021). Pimicotinib is a novel, orally administered, highly selective, and potent small-molecule inhibitor
(RTTNews) - Abbisko Therapeutics Co., Ltd. announced that the U.S. Food and Drug Administration (FDA) has formally accepted the New Drug Application (NDA) for pimicotinib (ABSK021). Pimicotinib is a novel, orally administered, highly selective, and potent small-molecule inhibitor